NDC 63629-7688

Lovastatin

Lovastatin

Lovastatin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Lovastatin.

Product ID63629-7688_397e3db6-3f85-4ad1-affb-a287ee97a23a
NDC63629-7688
Product TypeHuman Prescription Drug
Proprietary NameLovastatin
Generic NameLovastatin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2002-11-25
Marketing CategoryANDA / ANDA
Application NumberANDA075991
Labeler NameBryant Ranch Prepack
Substance NameLOVASTATIN
Active Ingredient Strength20 mg/1
Pharm ClassesHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 63629-7688-1

30 TABLET in 1 BOTTLE (63629-7688-1)
Marketing Start Date2019-04-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63629-7688-3 [63629768803]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

NDC 63629-7688-6 [63629768806]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

NDC 63629-7688-4 [63629768804]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

NDC 63629-7688-5 [63629768805]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

NDC 63629-7688-1 [63629768801]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

NDC 63629-7688-2 [63629768802]

Lovastatin TABLET
Marketing CategoryANDA
Application NumberANDA075991
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-25
Marketing End Date2019-08-07

Drug Details

Active Ingredients

IngredientStrength
LOVASTATIN20 mg/1

OpenFDA Data

SPL SET ID:1d0db1c1-89f9-4366-bd09-d99809f2352b
Manufacturer
UNII

Pharmacological Class

  • HMG-CoA Reductase Inhibitor [EPC]
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

NDC Crossover Matching brand name "Lovastatin" or generic name "Lovastatin"

NDCBrand NameGeneric Name
0093-0576LovastatinLovastatin
0093-0926LovastatinLovastatin
0093-0928LovastatinLovastatin
0185-0070LovastatinLovastatin
0185-0072LovastatinLovastatin
0185-0074LovastatinLovastatin
0440-6694LovastatinLovastatin
0615-5589LovastatinLovastatin
0615-6551LovastatinLovastatin
0615-6590LovastatinLovastatin
0615-7674LovastatinLovastatin
0615-7679LovastatinLovastatin
0615-7685LovastatinLovastatin
0615-7690LovastatinLovastatin
0615-8151Lovastatinlovastatin
0615-8152Lovastatinlovastatin
10544-235LovastatinLovastatin
10544-241LovastatinLovastatin
10544-242LovastatinLovastatin
10544-246LovastatinLovastatin
21695-534LovastatinLovastatin
21695-535LovastatinLovastatin
21695-536LovastatinLovastatin
33261-547LovastatinLovastatin
33261-548LovastatinLovastatin
33261-549LovastatinLovastatin
35356-885LovastatinLovastatin
42254-025LovastatinLovastatin
42254-028LovastatinLovastatin
42254-106LovastatinLovastatin
68001-224LovastatinLovastatin
68001-315LovastatinLovastatin
68001-316LovastatinLovastatin
68001-214LovastatinLovastatin
68001-314LovastatinLovastatin
68071-3108LovastatinLovastatin
68071-1973LovastatinLovastatin
68071-3127LovastatinLovastatin
68071-3261LovastatinLovastatin
68071-3397LovastatinLovastatin
68071-4271LovastatinLovastatin
68084-559LovastatinLovastatin
68180-468LovastatinLovastatin
68180-467LovastatinLovastatin
68180-469LovastatinLovastatin
68645-576LovastatinLovastatin
68645-566LovastatinLovastatin
68788-2634LovastatinLovastatin
68645-567LovastatinLovastatin
68788-0926LovastatinLovastatin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.